Free Republic

Cancer doctors have grown accustomed to good news. Over the past three decades, lung cancer deaths have plummeted by 40%. Breast cancer mortality has dropped 44%. Prostate cancer deaths have fallen by half. Colon cancer, once a leading killer, now claims 50% fewer lives than in 1990. These victories represent billions in research funding, surgical innovations, targeted therapies, and nationwide screening campaigns—the sum total of modern medicine’s war on cancer. Yet one malignancy refuses to follow the script. Pancreatic cancer—the silent executioner lurking behind the stomach, wrapped around vital blood vessels, often symptomless until the final act—is not only resisting...

Dilbert creator Scott Adams has revealed that his health has taken a turn for the worse, though there is still hope he could recover with the help of doctors. As The Gateway Pundit reported, Adams announced earlier this year he had stage 4 prostate cancer that had metastasized to his bones back in May. “I have the same cancer that Joe Biden has,” Adams said at the time. “I also have prostate cancer that has also spread to my bones. I’ve had it longer than he’s had it – well, longer than admitting that he’s had it, so my life...

Israeli researchers have reported a new treatment for advanced‑stage classical Hodgkin lymphoma (a type of cancer of the white blood cells) that achieved a 100% one‑year overall survival rate in a large cohort of patients participating in their program. Israeli researchers have unveiled an innovative treatment for advanced-stage Hodgkin lymphoma that they say resulted in a one-year survival rate of 100 per cent, representing a “true revolution” in caring for people with the disease. While traditionally the management of patients with advanced-stage classical Hodgkin lymphoma has relied exclusively on chemotherapy, the new treatment combines advanced chemotherapy with targeted biological therapy....

There's conspiracy theories, and then theres Patrick Soon-Shiong, the surgeon who owns the LA Times, talking about how he's now seeing spike proteins "from COVID" in the aggressive tumors of his patients. A billionaire oncologist just went on national television and said the words millions have been waiting to hear publicly.Dr. Patrick Soon-Shiong – the surgeon who invented the nanoparticle chemotherapy Abraxane, sold companies for billions, and now owns the LA Times – appeared… pic.twitter.com/ZWA960vha9— Camus (@newstart_2024) November 30, 2025Chris Cuomo: 'When you look in tumors what are you seeing? Dr. Soon-Shiong: 'There's now evidence that when you actually biopsy...

Progress in cutting the global toll of cancer remains painfully slow, but a new blood test has sparked unusual levels of hope. Researchers say it could one day make routine screening far more effective by catching cancers earlier, when treatment has the best chance of saving lives. The Galleri blood test, developed by US firm Grail, is the latest entrant to attract worldwide attention, after early trial results were described as “exciting” by researchers. A press release claims the test, currently being trialled by the NHS, can detect signals from 50 cancers and correctly identify the disease in 62% of...

[H/T ExTexasRedhead]The Nobel prize winning miracle drug Ivermectin works as an antiviral, anticancer, is part of a Lyme Disease cure protocol, and even reverses dementia, all while having a safety profile that is far superior to aspirin or any “vaccine” for that matter.Cancer surgeon Dr. Kathleen Ruddy had the following to say about Ivermectin:Cancer Surgeon: “Ivermectin Is SAFER Than a Sugar Pill” 👁️“You’d have to take a lot to make yourself sick.”Dr. Kathleen Ruddy has also observed multiple late-stage cancer patients make dramatic recoveries after taking ivermectin.Ivermectin is also:• A Nobel Prize-winning discovery (2015)• Recognized, 2nd to penicillin, for having...

Findings are "important milestone" in a field where AI has yet to prove clinical use, expert saysKey Takeaways -In a confirmatory study, AI achieved statistically non-inferior and superior performance in detecting pancreatic cancer compared with a pool of participating radiologists. -At matched sensitivity levels, the AI system reduced the number of false positives compared with radiologists. -AI could help diagnose pancreatic cancer sooner, and more accurately, an expert suggested. -An artificial intelligence (AI) system outperformed radiologists in detecting pancreatic ductal adenocarcinoma (PDAC) on routine CT scans, according to a non-inferiority, confirmatory, observational study. In a testing cohort of 1,130 patients,...

Scientists have uncovered how the gut microbiota help the immune system fight melanoma, explaining why patients with a fiber-rich diet and balanced gut bacteria tend to respond better to cancer immunotherapies. The study shows that molecules produced by gut bacteria upon digestion of dietary fiber can improve the function of cancer-fighting immune cells. The research team found that these digestive by-products influence melanoma progression by naturally boosting killer T cell function in pre-clinical cancer models. "Melanoma patients undergoing immunotherapy can benefit from a fiber-rich diet and previous studies suggested that what we eat affects the immune system. However, how that...

Two FDA-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study. AML, a cancer of blood and bone marrow, can affect people of all ages but is the most common type of leukemia in adults. The research tested the ability of the two drugs—apalutamide and finasteride—to treat leukemia in experimental models. They found that the drugs were effective in treating mice with AML as well as patient-derived AML cells. K. Sandeep Prabhu said the drugs work by inhibiting the pathway that is activated by dihydrotestosterone—an androgen hormone more potent than...

Skin cancer can be confusing…Firstly, any type of skin cancer is concerning. That’s why it’s important to pay attention to your skin and see a dermatologist at least once a year to see if any moles, freckles or growths are of concern.But some skin cancers have a much higher degree of risk for metastasizing, like melanoma. While melanoma is rare, accounting for only 1 percent of skin cancer cases, it represents the majority of skin cancer deaths.Then there are non-melanoma skin cancers, like basal cell carcinomas (BCC) and squamous cell carcinomas (SCC), the two most common types of skin cancer.Both...

A new study explores a radical idea: instead of killing cancer, what if we could heal it? In glioblastoma patients, a simple nutraceutical combination of resveratrol and copper appeared to reduce tumor aggressiveness and key cancer hallmarks without side effects. A new study indicates that glioblastoma becomes less aggressive after treatment with resveratrol and copper, a potentially game-changing finding that could pave the way for a radically new approach to cancer therapy. Treatments such as chemotherapy, radiotherapy and immunotherapy are all designed with a single goal in mind: to destroy cancer. However, what if this long-standing approach is wrong, and...

Tucker Carlson has crossed the line, but is he taking conservatives with him?...

President Donald Trump on Sunday publicly confirmed that he was working to help "Dilbert" creator Scott Adams secure treatment for prostate cancer. Adams publicly reached out to Trump seeking his aid the same day. Trump promptly responded by sharing Adams's plea and simply saying "on it." Earlier in the day, Adams's plea for assistance went viral on X after he announced that he had been unable to schedule his treatment for a recently approved drug. "On Monday, I will ask President Trump, via X, to help save my life. He offered to help me if I needed it. I need...

Survival rates for children with multi-metastatic Ewing’s sarcoma — a kind of bone cancer which has spread to multiple parts of the body — are ‘dismal’, scientists say. The five-year survival rate for children with this cancer is very low — some studies suggest less than a quarter reach this milestone. But a small non-randomized retrospective study of a drug called pazopanib has shown that it increases children’s survival without major side-effects. 85% of patients taking the drug survived for two years after diagnosis, and two-thirds reached the end of the second year without their cancer progressing. Researchers urge the...

In the new method, researchers from the University of Texas at Austin fired infrared light, a type of light invisible to the eye, from LED bulbs at test tubes that contained human skin cancer or colon cancer cells and healthy human skin cells. The tubes also contained nanoscopic flakes of tin oxide, or SnOx nanoflakes, which were absorbed by the cancer cells. The scientists found that when the light was fired at the cells, the nanoscopic flakes absorbed it and heated up, turning into 'microscopic heaters' that damaged cancer cells and caused them to die, while leaving the healthy cells...

It’s not just women that Cartel Medicine feeds on, although it does prefer them. Men are also meat for the grinder, especially when their privates are involved. The screening hoax we witnessed with mammograms has a counterpart with prostates and the PSA test. The predation here is especially synergistic as the maiming and destruction caused by prostate interventions feed two sub-Cartels: those of erectile dysfunction and incontinence. The adult diaper business is thriving because of this butchery. Urologists, not wanting to be left behind by pediatricians, psychiatrists, cardiologists, dermatologists and dentists have their own cozy racket. With thanks to Richard...

In a recent clinical trial, a low dose of aspirin reduced the risk of colon and rectal cancer recurrence by half in patients whose tumors carried a specific genetic mutation. Just 160 milligrams of aspirin daily—about half a pill of a standard adult tablet—reduced cancer recurrence by around 60 percent in a certain patient subgroup. These patients carried mutations in the PI3K gene, which affects about a third of all colorectal cancer patients. “Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which is very positive,” lead study author Dr. Anna...

The prostate-specific antigen (PSA) test has screened 30 million American men annually for over three decades. The man who discovered PSA in 1970, Richard Ablin, now calls mass screening “a public health disaster.” Two landmark 2012 studies found no survival benefit from radical surgery compared to watchful waiting. The U.S. Preventive Services Task Force concluded PSA screening does more harm than good. Yet the $3 billion annual industry continues largely unabated. These revelations emerge from three insider accounts: Ablin’s The Great Prostate Hoax, urologist Anthony Horan’s The Rise and Fall of the Prostate Cancer Scam, and oncologist Mark Scholz’s Invasion...

COVID-19 vaccines and boosters — both mRNA and non-mRNA — pose an increased risk of six types of cancer and a 27% higher risk of cancer overall, according to a recent South Korean study of over 8 million people. Four South Korean researchers published the report last week as a letter in Biomarker Research, a Springer Nature journal. According to the study, COVID-19 vaccines and boosters are associated with a higher risk of breast, colorectal, gastric, lung, prostate and thyroid cancer, across all vaccine types and age groups. Mainstream medical commentators were quick to dismiss the findings, with MedPageToday describing...

3-year survival twice as high with mRNA vaccine in lung cancer patients receiving immunotherapyNon-small cell lung cancer (NSCLC) patients starting immunotherapy were nearly twice as likely to be alive 3 years later if they got a COVID-19 vaccine around the time of treatment, a researcher reported here. Retrospective data in advanced NSCLC found that mRNA COVID vaccination within 100 days of initiating a checkpoint inhibitor was associated with higher 3-year survival rates compared with no vaccination (55.8% vs 30.6%; adjusted HR 0.51, 95% CI 0.37-0.71, P<0.0001), according to Adam Grippin, MD, PhD, of the University of Texas MD Anderson Cancer...